Australian medicines access package includes biosimilar substitution, price cuts
This article was originally published in Scrip
Executive Summary
The Australian government has produced a new five-year package designed to ensure patient access to medicines subsidized under the Pharmaceutical Benefits Scheme (PBS) while promoting the scheme's sustainability and the quality use of medicines.